tetano
Editor, Senior Moderator
Diagnostics (Basel)
. 2021 Mar 29;11(4):606.
doi: 10.3390/diagnostics11040606.
Vascular Abnormalities Detected with Chest CT in COVID-19: Spectrum, Association with Parenchymal Lesions, Cardiac Changes, and Correlation with Clinical Severity (COVID-CAVA Study)
Salah D Qanadli[SUP] 1 [/SUP], Alexander W Sauter[SUP] 2 [/SUP], Hatem Alkadhi[SUP] 3 [/SUP], Andreas Christe[SUP] 4 [/SUP], Pierre-Alexandre Poletti[SUP] 5 [/SUP], Lukas Ebner[SUP] 6 [/SUP], David C Rotzinger[SUP] 1 [/SUP]
Affiliations
Abstract
Although vascular abnormalities are thought to affect coronavirus disease 2019 (COVID-19) patients' outcomes, they have not been thoroughly characterized in large series of unselected patients. The Swiss national registry coronavirus-associated vascular abnormalities (CAVA) is a multicentric cohort of patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection who underwent a clinically indicated chest computed tomography (CT) aiming to assess the prevalence, severity, distribution, and prognostic value of vascular and non-vascular-related CT findings. Clinical outcomes, stratified as outpatient treatment, inpatient without mechanical ventilation, inpatient with mechanical ventilation, or death, will be correlated with CT and biological markers. The main objective is to assess the prevalence of cardiovascular abnormalities-including pulmonary embolism (PE), cardiac morphology, and vascular congestion. Secondary objectives include the predictive value of cardiovascular abnormalities in terms of disease severity and fatal outcome and the association of lung inflammation with vascular abnormalities at the segmental level. New quantitative approaches derived from CT imaging are developed and evaluated in this study. Patients with and without vascular abnormalities will be compared, which is supposed to provide insights into the prognostic role and potential impact of such signs on treatment strategy. Results are expected to enable the development of an integrative score combining both clinical data and imaging findings to predict outcomes.
Keywords: COVID-19; computed tomography; perfusion; pulmonary embolism; respiratory failure; vascular congestion.
. 2021 Mar 29;11(4):606.
doi: 10.3390/diagnostics11040606.
Vascular Abnormalities Detected with Chest CT in COVID-19: Spectrum, Association with Parenchymal Lesions, Cardiac Changes, and Correlation with Clinical Severity (COVID-CAVA Study)
Salah D Qanadli[SUP] 1 [/SUP], Alexander W Sauter[SUP] 2 [/SUP], Hatem Alkadhi[SUP] 3 [/SUP], Andreas Christe[SUP] 4 [/SUP], Pierre-Alexandre Poletti[SUP] 5 [/SUP], Lukas Ebner[SUP] 6 [/SUP], David C Rotzinger[SUP] 1 [/SUP]
Affiliations
- PMID: 33805443
- DOI: 10.3390/diagnostics11040606
Abstract
Although vascular abnormalities are thought to affect coronavirus disease 2019 (COVID-19) patients' outcomes, they have not been thoroughly characterized in large series of unselected patients. The Swiss national registry coronavirus-associated vascular abnormalities (CAVA) is a multicentric cohort of patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection who underwent a clinically indicated chest computed tomography (CT) aiming to assess the prevalence, severity, distribution, and prognostic value of vascular and non-vascular-related CT findings. Clinical outcomes, stratified as outpatient treatment, inpatient without mechanical ventilation, inpatient with mechanical ventilation, or death, will be correlated with CT and biological markers. The main objective is to assess the prevalence of cardiovascular abnormalities-including pulmonary embolism (PE), cardiac morphology, and vascular congestion. Secondary objectives include the predictive value of cardiovascular abnormalities in terms of disease severity and fatal outcome and the association of lung inflammation with vascular abnormalities at the segmental level. New quantitative approaches derived from CT imaging are developed and evaluated in this study. Patients with and without vascular abnormalities will be compared, which is supposed to provide insights into the prognostic role and potential impact of such signs on treatment strategy. Results are expected to enable the development of an integrative score combining both clinical data and imaging findings to predict outcomes.
Keywords: COVID-19; computed tomography; perfusion; pulmonary embolism; respiratory failure; vascular congestion.